Johnson & Johnson Receives Positive Chmp Opinion for Yuvanci® (Single Tablet Combination Therapy [Stct] of Macitentan and Tadalafil) for Treatment of Patients With Pulmonary Arterial Hypertension (Pah)
強生公司獲得正面的歐洲藥品管理局意見,認可Yuvanci®(馬西替尼和他達拉非組合片劑)用於治療肺動脈高壓患者。